Kestra Private Wealth Services LLC Purchases 2,515 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Kestra Private Wealth Services LLC increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 7.6% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 35,728 shares of the healthcare conglomerate’s stock after acquiring an additional 2,515 shares during the period. Kestra Private Wealth Services LLC’s holdings in UnitedHealth Group were worth $18,810,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in UNH. Wellington Management Group LLP lifted its position in shares of UnitedHealth Group by 2.1% during the 3rd quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock worth $12,715,790,000 after buying an additional 527,526 shares during the period. Northern Trust Corp boosted its stake in shares of UnitedHealth Group by 3.6% in the 3rd quarter. Northern Trust Corp now owns 9,787,768 shares of the healthcare conglomerate’s stock valued at $4,934,895,000 after purchasing an additional 341,749 shares in the last quarter. Bank of New York Mellon Corp increased its position in shares of UnitedHealth Group by 2.2% during the 3rd quarter. Bank of New York Mellon Corp now owns 8,242,282 shares of the healthcare conglomerate’s stock worth $4,155,676,000 after purchasing an additional 180,331 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its position in UnitedHealth Group by 0.5% in the third quarter. Charles Schwab Investment Management Inc. now owns 5,843,207 shares of the healthcare conglomerate’s stock valued at $2,937,976,000 after buying an additional 27,127 shares in the last quarter. Finally, Sanders Capital LLC increased its holdings in shares of UnitedHealth Group by 6.5% during the third quarter. Sanders Capital LLC now owns 5,757,410 shares of the healthcare conglomerate’s stock worth $2,902,829,000 after buying an additional 352,710 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently weighed in on UNH. Piper Sandler raised their price target on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a report on Wednesday, April 17th. Barclays upped their price target on shares of UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. HSBC upgraded shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 target price on the stock in a research report on Thursday, April 4th. Royal Bank of Canada dropped their price objective on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research report on Wednesday, April 17th. Finally, Stephens restated an “overweight” rating and set a $605.00 target price on shares of UnitedHealth Group in a research report on Thursday, February 8th. Four equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $570.05.

UnitedHealth Group Trading Down 1.3 %

UNH traded down $6.35 during mid-day trading on Monday, hitting $489.00. The stock had a trading volume of 2,192,486 shares, compared to its average volume of 4,479,956. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The stock’s fifty day simple moving average is $485.19 and its 200-day simple moving average is $513.81. The firm has a market capitalization of $449.92 billion, a price-to-earnings ratio of 29.89, a price-to-earnings-growth ratio of 1.43 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same period in the prior year, the company earned $6.26 earnings per share. The company’s revenue for the quarter was up 8.6% compared to the same quarter last year. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a yield of 1.54%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s payout ratio is presently 45.97%.

Insider Buying and Selling at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.